Cite
Immunotherapeutic hydrogel for co-delivery of STAT3 siRNA liposomes and lidocaine hydrochloride for postoperative comprehensive management of NSCLC in a single application
MLA
Xianglei Fu, et al. “Immunotherapeutic Hydrogel for Co-Delivery of STAT3 SiRNA Liposomes and Lidocaine Hydrochloride for Postoperative Comprehensive Management of NSCLC in a Single Application.” Asian Journal of Pharmaceutical Sciences, vol. 19, no. 3, June 2024. EBSCOhost, https://doi.org/10.1016/j.ajps.2024.100925.
APA
Xianglei Fu, Yanbin Shi, Zili Gu, Hengchang Zang, Lian Li, Qingjie Wang, Yongjun Wang, Xiaogang Zhao, Hang Wu, Shengnan Qiu, Yankun Zhang, Jiamin Zhou, Xiangqin Chen, Hua Shen, & Guimei Lin. (2024). Immunotherapeutic hydrogel for co-delivery of STAT3 siRNA liposomes and lidocaine hydrochloride for postoperative comprehensive management of NSCLC in a single application. Asian Journal of Pharmaceutical Sciences, 19(3). https://doi.org/10.1016/j.ajps.2024.100925
Chicago
Xianglei Fu, Yanbin Shi, Zili Gu, Hengchang Zang, Lian Li, Qingjie Wang, Yongjun Wang, et al. 2024. “Immunotherapeutic Hydrogel for Co-Delivery of STAT3 SiRNA Liposomes and Lidocaine Hydrochloride for Postoperative Comprehensive Management of NSCLC in a Single Application.” Asian Journal of Pharmaceutical Sciences 19 (3). doi:10.1016/j.ajps.2024.100925.